138 related articles for article (PubMed ID: 30233644)
1. Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population.
Wang C; Pu W; Zhao D; Zhou Y; Lu T; Chen S; He Z; Feng X; Wang Y; Li C; Li S; Jin L; Guo S; Wang J; Wang M
Front Genet; 2018; 9():356. PubMed ID: 30233644
[TBL] [Abstract][Full Text] [Related]
2. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma.
Bian Y; Gao Y; Lu C; Tian B; Xin L; Lin H; Zhang Y; Zhang X; Zhou S; Wan K; Zhou J; Li Z; Chen H; Wang L
Chin Med J (Engl); 2023 Aug; ():. PubMed ID: 37650127
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
5. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide methylation profiling identify hypermethylated HOXL subclass genes as potential markers for esophageal squamous cell carcinoma detection.
Yu Q; Xia N; Zhao Y; Jin H; Chen R; Ye F; Chen L; Xie Y; Wan K; Zhou J; Zhou D; Lv X
BMC Med Genomics; 2022 Nov; 15(1):247. PubMed ID: 36447287
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.
Huang J; Wang G; Tang J; Zhuang W; Wang LP; Liou YL; Liu YZ; Zhou HH; Zhu YS
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28241446
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC).
Guo S; Yan F; Xu J; Bao Y; Zhu J; Wang X; Wu J; Li Y; Pu W; Liu Y; Jiang Z; Ma Y; Chen X; Xiong M; Jin L; Wang J
Clin Epigenetics; 2015; 7(1):3. PubMed ID: 25657825
[TBL] [Abstract][Full Text] [Related]
10. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
[TBL] [Abstract][Full Text] [Related]
12. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing.
Xing S; Zheng X; Wei LQ; Song SJ; Liu D; Xue N; Liu XM; Wu MT; Zhong Q; Huang CM; Zeng MS; Liu WL
J Cancer; 2017; 8(12):2346-2355. PubMed ID: 28819439
[TBL] [Abstract][Full Text] [Related]
17. Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China.
Wang KL; Chen XL; Lei L; Li P; Hong LL; Huang XC; Mao WM; Mukaisho K; Ling ZQ
J Cancer; 2019; 10(16):3624-3631. PubMed ID: 31333779
[TBL] [Abstract][Full Text] [Related]
18. Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms.
Zheng D; Ding Y; Ma Q; Zhao L; Guo X; Shen Y; He Y; Wei W; Liu F
Front Oncol; 2018; 8():674. PubMed ID: 30719423
[No Abstract] [Full Text] [Related]
19. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
[TBL] [Abstract][Full Text] [Related]
20. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
